CHI3L1 and Alzheimer disease: In our previous work, serum CHI3L1 concentrations were significantly higher in AD patients compared to cognitively normal controls, and receiver operating characteristic (ROC) analysis indicated its promise as a reliable diagnostic indicator (Ham et al., 2024).